BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Apricus Biosciences 

6330 Nancy Ridge Drive
Suite 103
San Diego  California  92121  U.S.A.
Phone: 858-222-8041 Fax: 858-866-0482


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Drug Delivery





 Company News
Apricus Biosciences (APRI) Appoints Barbara Troupin, M.D. As Chief Medical Officer 12/15/2014 8:11:26 AM
Apricus Biosciences (APRI) Announces First Patient Enrolled In Phase 2a Clinical Trial For Rayva In Patients With Raynaud's Phenomenon 12/4/2014 10:29:46 AM
Apricus Biosciences (APRI) Appoints Brian T. Dorsey As Chief Development Officer 12/2/2014 11:55:37 AM
Apricus Biosciences (APRI) Announces Third Quarter 2014 Financial Results And Provides Corporate Update 11/10/2014 8:13:13 AM
Apricus Biosciences (APRI) To Present At Three Upcoming Investor Conferences In November And December Of 2014 11/5/2014 10:13:28 AM
Apricus Biosciences (APRI) Announces Corporate Update And Third Quarter 2014 Financial Results Conference Call 11/4/2014 7:28:18 AM
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014 8:53:35 AM
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014 1:15:18 PM
Apricus Biosciences (APRI) Expands Development Pipeline With The In-Licensing Of U.S. Rights For Fispemifene, A Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions In Men 10/20/2014 6:22:45 AM
Apricus Biosciences (APRI) Announces Notice Of Allowance Of U.S. Patent Application For Rayva™ 10/13/2014 7:54:48 AM
12345678910...